Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)

1d ago, source: The Wall Street Transcript

You’ve spoken to TWST before, but just for our readers who may not remember, can you give us a brief overview of the origins of the company and how it has grown or evolved over the years? Dr.

PDS Biotechnology (NASDAQ: PDSB)

18h ago, source: The Motley Fool

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer ...

PDS Biotechnology Corporation (PDSB)

3d ago, source: Yahoo Finance

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript March 27, 2024 PDS Biotechnology Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of ...

PDS Biotechnology Corp PDSB

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PDS Biotechnology gets grant for vaccine composition with cationic lipid for immune response enhancement

2d ago, source: Pharmaceutical Technology

Discover how PDS Biotechnology's patented vaccine compositions with cationic lipids boost immune responses in mammals, offering a promising approach to comprehensive disease prevention and treatment.

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript

22d ago, source: Hosted on MSN

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript March 27, 2024 PDS Biotechnology Corporation isn't one of the 30 most popular stocks among hedge funds at the end of ...

Q4 2023 PDS Biotechnology Corp Earnings Call

23d ago, source: Yahoo Finance

Riley Financial, Inc. James Molloy; Analyst; Alliance Global Partners Operator Good morning, and welcome to PDS Biotech's call to discuss the company's year-end 2023 financial results and clinical ...

PDS Biotechnology Corporation (PDSB) Stock: A Look at the Monthly Trend

8d ago, source: newsheater

PDSB stock has gone down by -0.61%, with a monthly decline of -29.30% and a quarterly plunge of -33.40%. The volatility ratio for the week is 8.35%, and the volatility levels for the last 30 days are ...

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript

23d ago, source: Insider Monkey

PDS Biotechnology Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. And welcome to PDS Biotech ...

PDS Biotechnology Corporation (PDSB) Q4 2023 Earnings Call Transcript

23d ago, source: Seeking Alpha

Good morning. And welcome to PDS Biotech's call to discuss the company's Year-End 2023 Financial Results and Clinical Strategy Update Conference Call. All participants are currently in listen-only ...